Technology
Health
Medical
Alphatec
$4.159876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$4.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.29 (-6.53%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell Alphatec and other stocks, options, ETFs, and crypto commission-free!
About
Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. Read More The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.
Employees
195
Headquarters
Carlsbad, California
Founded
2005
Market Cap
193.29M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
241.33K
High Today
$4.50
Low Today
$4.10
Open Price
$4.45
Volume
258.24K
52 Week High
$4.79
52 Week Low
$1.18
Collections
Technology
Health
Medical
Advertising and Marketing
Business Services
US
North America
News
Seeking AlphaMay 11
Alphatec Holdings, Inc. 2019 Q1 - Results - Earnings Call Slides
The following slide deck was published by Alphatec Holdings, Inc. in conjunction with their 2019 Q1 earnings call. 1 22 Click to enlarge Notes:...
Yahoo FinanceMay 9
Alphatec Reports Q1 Loss, Tops Revenue Estimates
Alphatec (ATEC) delivered earnings and revenue surprises of 0.00% and 2.31%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Yahoo FinanceMay 9
Alphatec Reports First Quarter 2019 Financial Results and Corporate Highlights
Strong Early Traction from New Products Drives U.S. Revenue Growth of 20% CARLSBAD, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2019, and recent corporate highlights. First Quarter 2019 Financial Highlights Total net revenue of $24.6 million; U.S. product revenue of $23.0 mill...
Price Paid on Robinhood
69% Higher
Right Now
52 Week Low
$1.18
Average Price Paid
$2.46
52 Week High
$4.79
Earnings
-$0.39
-$0.26
-$0.13
$0.00
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.21 per share
Actual
-$0.29 per share